未登录

S

Sean O'Quinn

Sanofi-Aventis

H指数:11

被引数:702

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2022-05-017

OAAI

Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY

IF6.8

2022-01-103

OA

Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents

成人和青少年嗜酸性胃炎和嗜酸性胃肠炎症状评估的开发和内容验证

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2021-11-246

OAAI

Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma

JOURNAL OF ASTHMA AND ALLERGY

IF3

2021-06-0114

OAAI

COMPARISON OF ASTHMA CONTROL AND TREATMENT EFFECTIVENESS ASSESSMENTS BETWEEN US PATIENTS WITH ASTHMA AND TREATING SUBSPECIALISTS: REAL-WORLD DATA FROM THE CHRONICLE STUDY

IF8.6

2019-10-010

PREAI

COMPARISON OF ASTHMA CONTROL AND TREATMENT EFFECTIVENESS ASSESSMENTS BETWEEN US PATIENTS WITH ASTHMA AND TREATING SUBSPECIALISTS: REAL-WORLD DATA FROM THE CHRONICLE STUDY

IF8.6

2019-10-010

OAAI

Benralizumab for the Prevention of COPD Exacerbations

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2019-09-12200

OAAI

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma

JOURNAL OF ASTHMA AND ALLERGY

IF3

2019-01-0112

OAAI

Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2018-02-016

OAAI

Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis

RESPIRATORY MEDICINE

IF3.1

2018-01-0112

OAAI

ASTHMA SYMPTOM IMPROVEMENTS WITH BENRALIZUMAB ARE ASSOCIATED WITH IMPROVEMENTS IN ACTIVITY FUNCTIONS AND QUALITY OF LIFE FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS OF POOLED PHASE III BENRALIZUMAB STUDIES

IF7.7

2017-11-151

OAAI

Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD)

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2016-07-1612

OAAI

Idiopathic Pulmonary Fibrosis in United States Automated Claims Incidence, Prevalence, and Algorithm Validation

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IF19.4

2015-11-1595

PREAI

THE EXACT IN IDIOPATHIC PULMONARY FIBROSIS (IPF): CONTENT VALIDITY OF AN EXISTING PATIENT-REPORTED OUTCOME MEASURE FOR USE IN A RARE DISEASE

VALUE IN HEALTH

IF6

2013-05-010

OAAI

A New Measure of Caregiver Burden in Alzheimer's Disease: The Caregiver-Perceived Burden Questionnaire

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS

IF2.7

2012-08-1614

OAAI